Male and female patients will be eligible for enrollment Females should be either of non-childbearing potential as a result of surgery radiational therapy menopause one year post onset or of childbearing potential and practicing a medically acceptable method of contraception eg abstinence a barrier method plus spermicide or intrauterine device IUD for at least three months before Visit 1 Screening and for two months after the end of the study They must also have a negative serum beta-human chorionic gonadotropin beta-hCG at Screening Pregnant and/or lactating females are excluded Those women using an oral contraceptive must also be using an additional approved method of contraception eg a barrier method plus spermicide or IUD starting with the Baseline Phase and continuing throughout the entire study period 